Mulberry swampeel sugar and lipid-lowering capsule

Abstract

The invention relates to a mulberry swampeel sugar and lipid-lowering capsule. The capsule is characterized in that the formula comprises: 3% of red ginseng, 4% of astragalus, 3% of ganoderma lucidum, 3% of Schisandra chinensis, 2% of kudzu vine root, 6% of Salvia Miltiorrhiza, 4% of Ligusticum wallichii, 6% of swampeel, 3% of semen cuscutae, 1% of black sesame, 5% of root of rehmannia, 6% of prepared rhizome of rehmannia, 5% of black fungus, 2% of a ginkgo leaf extract, 2% of spina date seed, 3% of ophiopogon japonicas, 3% of radix asparagi, 6% of mulberry leaf, 3% of mulberry, 4% of Gynostemma pentaphyllum, 3% of pearl powder, 2% of cassia seed, 2% of coix seed, 3% of corn stigma, 3% of Coptis chinensis, 4% of balsam pear, 2% of cape jasmine, 4% of malt, and 1% of licorice. The materials are extracted in proportion to make the capsule.

Description

technical field [0001] The invention relates to a mulberry eel capsule for reducing blood sugar, fat and blood pressure. Background technique [0002] There are many kinds of Chinese patent medicines for hypoglycemia, but few have a good reputation. According to the analysis, the main reason is that most of them focus on solving the three symptoms of diabetes described in traditional Chinese medicine, that is, the upper, middle, and lower problems. Focusing on the theory of islet cell repair in modern diabetes research, as well as the modern comprehensive theory of concurrent coronary heart disease, kidney disease, hypertension, and eye disease, the formula is based on the simple transformation of most of the traditional Chinese medicine prescriptions, without bold innovation from the biological point of view. Cause the pace of the modernization of traditional Chinese medicine to stagnate. Because the basis of the formula is lagging behind, its effect is difficult to break ...

AI Technical Summary

Problems solved by technology

[0002] There are many kinds of Chinese patent medicines for hypoglycemia, but few have a good reputation. According to the analysis, the main reason is that most of them focus on solving the three symptoms of diabetes described in traditional Chinese medicine, that is, the upper, middle, and lower problems. Focusing on the theory of islet cell repair in modern diabetes research, as well as the modern comprehensive theory of concurrent coronary heart disease, kidney disease, hypertension, and eye disease, the formula is based on the simple transformation of most of the traditional Chinese medicine prescriptions, without bold innovation from the biological point of view. Caused the pace of modernization of traditional Chinese medicine to stagnate

Because the basis of the formula is lagging behind, its effect is difficult to break through